About this trial
The purpose of this study is to examine the impact and cost effectiveness of a workplace-based intervention aimed at reducing prolonged occupational sitting among office-based workers. The study will be conducted in three phases. Phase I: is an Integrative review on economic evaluations of workplace-based interventions for reducing occupational sitting time. Phase II: is a secondary analysis of register data within the Northern Finland Birth Cohort 1966 (NFBC-1966). This is aimed at evaluating the association between prolonged sitting time with societal and/or organization economic perspective across different occupational categories at midlife. Phase III will be a Randomized Control Trial (RCT) of an office-based intervention designed to reduce prolonged occupational sitting time. The sample for the RCT will be 140 office-based workers - 70 participants will be enrolled in the control group whilst 70 participants will be enrolled within the intervention group. The study will be conducted from 2021 to 2025. An article-based dissertation will be completed at the end of the study, this will be mainly based on four articles that will be published in international peer reviewed journals.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
working at least six full time hours
Age of 18-65 years
Speaking Finnish language
Having designated access to internet
Disqualifiers
Non-ambulatory
Pregnant
Those participating in other RCTs
Those planning relocation
Trial design
Single group
Treatments tested in this trial
ISKE
BehavioralThe intervention will consist of an e-health software Programme that we have named "Istumisen Keskeyttäminen (ISKE)" will be installed on the desktop of participants. Functionality of the software: the primary purpose of the software is to remind users (basically office-based workers) to take a break on a regular basis (recommended time 30 minutes). At the end of the workday, the software provides information on the number of breaks taken and how long each lasted. The user will also have access to such information. What happens during the prompted break: once the software prompts the user to take a break, she/he can click the Continue button to proceed with the break. The software will include activities that are suggested for the user to do during break. After the break, the record of the time (duration of the break, and when the break was taken) can be taken.
Treatment groups
Trial outcomes
Primary outcomes
Physical activity
Physical activity will be objectively measured with the ActivePal accelerometer (PAL technologies LTD, Glasgow, UK). This is a thigh-worn, tri-axial accelerometer. The accelerometer was chosen because it is easy to use, discrete and can differentiate between sitting, standing, and stepping in varying postural transitions. Participants will be asked to wear the monitors for at least 14 days during workdays hours. The participants will then give the accelerometer to the researcher, data recorded on them will be downloaded and analyses.
Secondary outcomes
Cost
Costs will be measured using the full cohort data for the control and intervention group including intervention costs, visits to the occupational health care, participant time spent on intervention and estimated work loss costs due to absenteeism/ sickness absence.
Absenteeism
Work time missed,will be objectively measured through employer-recorded absence data for the intervention and control participants. Costs according to the reason of absence e.g., sickness leave will be obtained from the occupational health records and the employer.
Presenteeism
Impairment at work/ reduced on-the-job effectiveness will be measured with Presenteeism Scale.
Health related quality of life
will be measure with the Finnish version of the European Quality of Life with Five Domains (EQ-5D-5L), this questioner has three levels of quality in each domain.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Helsinki
Lead sponsor
University of Oulu
Collaborator
This trial is not recruiting at the moment. You can still explore other options: